Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral Immunodeficiency

Clinical trial NCT03492710 · WITHDRAWN

Trial details

NCT number: NCT03492710
Sponsor: Green Cross Corporation
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Immune Deficiency Disorder

Start date: 2019-04-30
Primary completion: 2019-04-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.